Key result
Mitral valve repair with patch augmentation of the posterior leaflet yielded an 8-year overall survival of 62.48% and 91.9% freedom from moderate or severe recurrent mitral regurgitation.
Why the study?
To evaluate the mid-term results of mitral valve repair with patch augmentation of the posterior leaflet in secondary mitral regurgitation.
Does mitral valve repair with patch augmentation of the posterior leaflet provide sustainable mid-term outcomes in patients with severe secondary mitral regurgitation?
Cohort (n=174)
Does mitral valve repair with patch augmentation of the posterior leaflet provide sustainable mid-term outcomes in patients with severe secondary mitral regurgitation?
Patch augmentation of the posterior mitral leaflet combined with remodelling annuloplasty is a safe technique that provides sustainable mid-term mitral valve competence in patients with severe secondary mitral regurgitation.
Patch augmentation may be feasible for type IIIb secondary MR; leaves open durability versus standard repair pending RCTs.
OBJECTIVES: We evaluate the mid-term results of mitral valve (MV) repair with patch augmentation of the posterior leaflet in secondary mitral regurgitation. METHODS: Patients were included after diagnosis of a severe symptomatic secondary MV insufficiency with grade III and IV according to the Carpentier classification IIIb. Indication for a patch augmentation technique was a dilatation of the left ventricle leading to a displacement of the papillary muscles, causing restricted leaflet motion and a marked leaflet tenting height. Data were collected prospectively between December 2011 and March 2020. RESULTS: In total, 174 patients (mean age: 65 ± 12 years) received an MV repair with patch augmentation of the posterior leaflet and a true-sized remodelling annuloplasty (mean size 30.8 mm). Causes of the MV incompetence were dilatative cardiomyopathy in 126 patients and ischaemic myocardial disease in 48 patients. Concomitant bypass surgery was performed in 28 patients, and the tricuspid valve was repaired in 68 patients. The mean follow-up was 40 ± 28.2 months. There was no 30-day mortality. In-hospital mortality was 1.2% (n = 2); late mortality was 10.9% (n = 19). At 8 years, overall survival was 62.48%, freedom from moderate or severe recurrent mitral regurgitation was 91.9% and freedom from reoperation due to MV insufficiency was 97.1%. CONCLUSIONS: Augmentation of the posterior MV leaflet in addition to remodelling annuloplasty is a safe and reproducible mitral reconstruction technique that renders sustainable MV competence.
No takes yet. Share an insight, caveat, or question.
Lakew et al. (2022) conducted a cohort in Secondary mitral valve insufficiency (n=174). Mitral valve repair with patch augmentation of the posterior leaflet and remodelling annuloplasty was evaluated on Overall survival at 8 years. Mitral valve repair with patch augmentation of the posterior leaflet yielded an 8-year overall survival of 62.48% and 91.9% freedom from moderate or severe recurrent mitral regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: